News results: "Genentech"

« 30 results in "Health"« 2 results in "Technology"« 1 results in "Science"
« 3 results in "Business"« 7 results in "Specials"« 2 results in "Gadgets"
dotclear

Health

FDA Warns 14 Drugmakers for “Misleading” Ads on the Internet

FDA Warns 14 Drugmakers for “Misleading” Ads on the Internet

The Food and Drug Administration on Friday faulted 14 pharmaceutical companies for...
» read full story April 04th, 2009 - 22:31
US Panel Backs Roche’s Avastin for Brain Cancer

US Panel Backs Roche’s Avastin for Brain Cancer

A panel of outside advisers to the Food and Drug Administration voted Tuesday in favor of Roche...
» read full story April 01st, 2009 - 14:27
Fatal Psoriasis Drug Banned

Fatal Psoriasis Drug Banned

The FDA issued a public health advisory February 19th regarding reports of a rare brain infection...
» read full story February 22nd, 2009 - 17:46
FDA: Three Deaths from PML Tied to Genentech Psoriasis Drug Raptiva

FDA: Three Deaths from PML Tied to Genentech Psoriasis Drug Raptiva

  Three patients taking Genentech’s psoriasis drug Raptiva are thought to have died of...
» read full story February 20th, 2009 - 14:26
Brand New Alzheimer’s Theory

Brand New Alzheimer’s Theory

U.S. biotechnology company Genentech Inc has published a new study in the journal Nature that...
» read full story February 20th, 2009 - 00:08
Discovery May Offer New Targets for Drug Development to Slow Alzheimer’s

Discovery May Offer New Targets for Drug Development to Slow Alzheimer’s

Researchers at Genentech of South San Francisco and the Salk Institute of La Jolla have...
» read full story February 19th, 2009 - 15:57
Erbitux Plus Other Cancer Drugs Not Helpful for Colorectal Cancer

Erbitux Plus Other Cancer Drugs Not Helpful for Colorectal Cancer

A Dutch study published in the Feb. 5 issue of the New England Journal of Medicine reveals that...
» read full story February 05th, 2009 - 14:58
Genentech Will Have Its Efficiency Results In Mid-April

Genentech Will Have Its Efficiency Results In Mid-April

After Amgen Inc, Genentech is the world’s second-biggest biotechnology company and is mainly...
» read full story January 21st, 2009 - 20:23
Small Breast Tumors May Need Extra Treatment

Small Breast Tumors May Need Extra Treatment

<!-- /* Style Definitions */ p.MsoNormal, li.MsoNormal,...
» read full story December 13th, 2008 - 12:30
Cancer Drug Avastin Meets Endpoint In Late Stage Trial

Cancer Drug Avastin Meets Endpoint In Late Stage Trial

The outcome of the most recent study of Avastin revealed that the cancer drug is indeed effective...
» read full story November 24th, 2008 - 21:12

Avastin Raises Risk of Blood Clots

An analysis of 15 clinical trials involving Genentech’s cancer drug Avastin has found that the...
» read full story November 20th, 2008 - 16:37
Avastin Drug Linked to Blood Clots

Avastin Drug Linked to Blood Clots

Research conducted by United States scientists has revealed that the Avastin cancer drug...
» read full story November 19th, 2008 - 19:56
Avastin Linked to Blood Clot Risk, New Analysis Finds

Avastin Linked to Blood Clot Risk, New Analysis Finds

Genentech’s cancer drug Avastin was linked to a significantly increased risk of blood clots in the...
» read full story November 19th, 2008 - 14:10
Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat

Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat

The drug Tarceva, made by OSI Pharmaceuticals has been found to cause an increase in survival rates...
» read full story November 08th, 2008 - 23:55
Tarceva Slows Progress Of Lung Cancer, Study Shows

Tarceva Slows Progress Of Lung Cancer, Study Shows

After a study disclosed that the drug Tarceva was efficient in prolonging lung cancer survival when...
» read full story November 08th, 2008 - 14:33
OSI Shares Gain, Despite Preliminary Results, Tarceva Meets Its Goal

OSI Shares Gain, Despite Preliminary Results, Tarceva Meets Its Goal

Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
» read full story November 08th, 2008 - 14:30
Genentech Seeks Regulatory Approval for Avastin Use in Brain Cancer

Genentech Seeks Regulatory Approval for Avastin Use in Brain Cancer

Drug maker Genentech Inc. seeks regulatory approval for its cancer drug Avastin in patients with...
» read full story November 04th, 2008 - 15:40
Prostate Gland, a Repository of Adult Stem Cells, Genentech Researchers Found

Prostate Gland, a Repository of Adult Stem Cells, Genentech Researchers Found

Researchers at Genentech, in San Francisco, found that the prostate contains adult stem cells that...
» read full story October 23rd, 2008 - 12:11

Genentech’s Avastin reaches Phase 3

Genentech has recently announced that the study of Avastin will continue as planned, reaching phase...
» read full story October 20th, 2008 - 22:42
FDA: Genentech Psoriasis Drug Raptiva to Get Warning on Fatal Infections

FDA: Genentech Psoriasis Drug Raptiva to Get Warning on Fatal Infections

The Food and Drug Administration announced today that the label of Genentech Inc's psoriasis...
» read full story October 17th, 2008 - 14:01
Combined Treatment of Rituxan and Chemotherapy Proves Efficient in Leukemia

Combined Treatment of Rituxan and Chemotherapy Proves Efficient in Leukemia

Genentech Inc. and Biogen Idec Inc. announced that their drug Rituxan combined with chemotherapy...
» read full story October 08th, 2008 - 14:40
Tarceva-Avastin Combination Doesn’t Prolong Lung Cancer Survival

Tarceva-Avastin Combination Doesn’t Prolong Lung Cancer Survival

According to the results of a late-stage clinical trial into the benefits of combining Genentech’s...
» read full story October 07th, 2008 - 14:00
Two-Drug Combination Isn’t Up To Snuff In Lung-Cancer Trial

Two-Drug Combination Isn’t Up To Snuff In Lung-Cancer Trial

Genentech Inc. and OSI Pharmaceuticals Inc., two leading biotechnology companies, announced Monday...
» read full story October 06th, 2008 - 22:31
Update: New Breast Cancer Vaccine Proves Efficient In Lab Experiment

Update: New Breast Cancer Vaccine Proves Efficient In Lab Experiment

An experimental breast cancer vaccine proved efficient in treating breast cancer caused by an...
» read full story September 15th, 2008 - 14:45
Case of Deadly Brain Infection Prompts Labeling Revisal for Rituxan

Case of Deadly Brain Infection Prompts Labeling Revisal for Rituxan

The labeling for cancer and rheumatoid arthritis drug Rituxan is being revised after the US Food...
» read full story September 12th, 2008 - 15:38

Rituxan Treatment Associated With Brain Disorder Death

The Food and Drug Administration says that a woman passed away due to a brain infection with...
» read full story September 12th, 2008 - 15:20
Rituximab + Antibodies Makes Kidney Transplant More Feasible

Rituximab + Antibodies Makes Kidney Transplant More Feasible

A new therapy appears to improve transplant rates and outcomes for patients waiting for kidney...
» read full story July 17th, 2008 - 16:25
Invitrogen’s Genetic Test for Breast Cancer Gets FDA Clearance

Invitrogen’s Genetic Test for Breast Cancer Gets FDA Clearance

The U.S. regulators approved on Tuesday a genetic test that allows doctors to...
» read full story July 09th, 2008 - 13:09
Genentech’s Cancer Drug Avastin Questioned over Its Price

Genentech’s Cancer Drug Avastin Questioned over Its Price

Genentech’s cancer drug Avastin is now facing a halt in approval for expanded use because of its...
» read full story July 07th, 2008 - 15:51
New Data Triggers Revision of Erbitrux vs. Avastin Study

New Data Triggers Revision of Erbitrux vs. Avastin Study

While the European Medicines Agency, based in London, has approved the use of Erbitux, produced by...
» read full story June 04th, 2008 - 22:37
dotclear

Technology

Reports: Government probes Apple-Google link

San Francisco  - The Federal Trade Commission is investigating the close relationship between...
» read full story May 05th, 2009 - 22:40
Google Launches Apps Reseller Program

Google Launches Apps Reseller Program

Google will launch on Wednesday a reseller program for the paid version of its Apps hosted...
» read full story January 14th, 2009 - 13:16
dotclear

Science

Avastin Drug Linked To Blood Clots

Avastin Drug Linked To Blood Clots

Research conducted by United States scientists has revealed that the Avastin cancer drug...
» read full story November 20th, 2008 - 11:00
dotclear

Business

Pharmaceutical firm Roche's first quarter sales increase

Basel - Roche, the Swiss pharmaceutical giant, said it was confident it would meet full year...
» read full story April 16th, 2009 - 15:36
OSI Shares Gain After Study Shows Tarceva Meets Its Goal

OSI Shares Gain After Study Shows Tarceva Meets Its Goal

Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
» read full story November 10th, 2008 - 06:58
Canalys: BlackBerry Overtaken By The iPhone In The Third Quarter

Canalys: BlackBerry Overtaken By The iPhone In The Third Quarter

Apple’s new iPhone appears to be winning ground on the U.S. corporate market, which up until...
» read full story November 08th, 2008 - 09:39
dotclear

Specials

FDA Wants 14 Drugmakers to Stop Misleading Ads

The Internet is full of promotional ads of drugs and I am sure you thought at least once in your...
» read full story April 05th, 2009 - 22:48
Psoriasis Drug Raptiva Tied to PML Deaths

Psoriasis Drug Raptiva Tied to PML Deaths

The Food and Drug Administration on Thursday said Genentech’s psoriasis drug Raptiva has...
» read full story February 21st, 2009 - 14:21
Pfizer Ends Phase III Trial Of Pancreatic Cancer Drug Axitinib

Pfizer Ends Phase III Trial Of Pancreatic Cancer Drug Axitinib

Pfizer Inc. halted a Phase III study of its experimental drug axitinib designed to cure advanced...
» read full story February 02nd, 2009 - 15:45
Study: Cancer Drug Avastin Increases Blood Cloths Risk

Study: Cancer Drug Avastin Increases Blood Cloths Risk

Avastin, Genentech’s best-selling drug, increases the risk of people developing blood clots,...
» read full story November 19th, 2008 - 16:48
Study: Lung Cancer Drug Tarceva Slows Progression of the Disease

Study: Lung Cancer Drug Tarceva Slows Progression of the Disease

Lung cancer drug Tarceva jointly developed by OSI Pharmaceuticals Inc., Genentech Inc. and Roche...
» read full story November 10th, 2008 - 15:08

FDA Warns about PML Case in Woman Taking Rituxan

A fatal case of progressive multifocal leukoencephalopathy, or PML, in a patient treated with...
» read full story September 14th, 2008 - 14:45
Genome Institute’s Renowned Director, Francis Collins, to Resign

Genome Institute’s Renowned Director, Francis Collins, to Resign

The National Human Genome Research Institute is losing one of its prestigious researchers in the...
» read full story May 29th, 2008 - 12:54
dotclear

Gadgets

iPhone Takes Second Place In Smartphone Market

iPhone Takes Second Place In Smartphone Market

Apple is already racking up blockbuster sales with consumers. The company is making small inroads...
» read full story November 09th, 2008 - 16:11
Apple Confronts RIM Head-On with Corporate Email Support

Apple Confronts RIM Head-On with Corporate Email Support

Phil Schiller, head of worldwide marketing for the maker of the iPhone, iPod and Mac line of...
» read full story March 07th, 2008 - 17:47
dotclear
dotclear
dotclear
Photos Gallery
dotclear